115 related articles for article (PubMed ID: 12148005)
1. A crystal clear solution for insulin delivery.
Merkle HP; Jen A
Nat Biotechnol; 2002 Aug; 20(8):789-90. PubMed ID: 12148005
[No Abstract] [Full Text] [Related]
2. Hybrid insulin cocrystals for controlled release delivery.
Brader ML; Sukumar M; Pekar AH; McClellan DS; Chance RE; Flora DB; Cox AL; Irwin L; Myers SR
Nat Biotechnol; 2002 Aug; 20(8):800-4. PubMed ID: 12134168
[TBL] [Abstract][Full Text] [Related]
3. [Insulin glargine (HOE901)].
Iwamoto Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():503-10. PubMed ID: 12387042
[No Abstract] [Full Text] [Related]
4. [Insulin detemir (NN304)].
Kaku K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():511-5. PubMed ID: 12387043
[No Abstract] [Full Text] [Related]
5. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
Sachse G; Federlin K
Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
[TBL] [Abstract][Full Text] [Related]
6. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
Kwon JH; Lee BH; Lee JJ; Kim CW
Eur J Pharm Sci; 2004 Jun; 22(2-3):107-16. PubMed ID: 15158896
[TBL] [Abstract][Full Text] [Related]
7. Insulin formulation and delivery.
Brange J; Langkjaer L
Pharm Biotechnol; 1997; 10():343-409. PubMed ID: 9160379
[No Abstract] [Full Text] [Related]
8. [Experiences with a depot-body-free delayed-action insulin].
Schliack V; Lotz U
Munch Med Wochenschr; 1967 Jun; 109(24):1328-33. PubMed ID: 5631747
[No Abstract] [Full Text] [Related]
9. Insulin.
Panesar P
Prof Nurse; 2004 Dec; 20(4):51-2. PubMed ID: 15624624
[TBL] [Abstract][Full Text] [Related]
10. New long-acting insulin available.
Mayo Clin Health Lett; 2001 Sep; 19(9):4. PubMed ID: 11547604
[No Abstract] [Full Text] [Related]
11. [Insulin analogues: place of detemir (Levemir)].
Dorchy H; Sternon J
J Pharm Belg; 2006; 61(2):58-62. PubMed ID: 16866083
[TBL] [Abstract][Full Text] [Related]
12. [Long acting insulin analogs: possibly more stable glucose regulation].
van der Wal PS; van de Kraats GB
Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248. PubMed ID: 15568633
[No Abstract] [Full Text] [Related]
13. Lantus reduces blood glucose levels, less hypoglycemia in treatment of type 2 diabetes.
Walczak IM
Diabetes Technol Ther; 2002; 4(5):735-6. PubMed ID: 12458566
[No Abstract] [Full Text] [Related]
14. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
15. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats.
Karathanasis E; Bhavane R; Annapragada AV
J Control Release; 2006 Jun; 113(2):117-27. PubMed ID: 16765471
[TBL] [Abstract][Full Text] [Related]
16. Insulin glargine (Lantus).
Owens DR; Griffiths S
Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
[TBL] [Abstract][Full Text] [Related]
17. [Insulins and insulin therapy].
Blacker C
Lille Med; 1976 Dec; 21(10):836-44. PubMed ID: 1018606
[No Abstract] [Full Text] [Related]
18. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
Zhao Y; Trewyn BG; Slowing II; Lin VS
J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
[TBL] [Abstract][Full Text] [Related]
19. [Experience in the treatment of diabetes mellitus with delayed-action insulin preparations].
Piasetskiĭ NR; Tirkina TN; Danilova NS
Klin Med (Mosk); 1967 May; 45(5):22-8. PubMed ID: 5607519
[No Abstract] [Full Text] [Related]
20. [Evaluation of the effect of delayed-action metformin in continuous blood sugar recording].
Lapinski H; Mirouze J
Diabete; 1971; 19(2):121-4. PubMed ID: 5115582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
